Vnitr Lek 2011, 57(5):435-436

Co způsobuje pokles úmrtnosti na ischemickou chorobu srdeční? - editorial

R. Cífková1,2,3
1 Centrum kardiovaskulární prevence 1. lékařské fakulty UK a Fakultní Thomayerovy nemocnice s poliklinikou Praha, přednostka prof. MUDr. Renata Cífková, CSc.
2 II. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Aleš Linhart, DrSc.
3 Pracoviště preventivní kardiologie IKEM Praha, přednostka doc. MUDr. Věra Adámková, CSc.

Received: April 7, 2011; Published: May 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cífková R. Co způsobuje pokles úmrtnosti na ischemickou chorobu srdeční? - editorial. Vnitr Lek. 2011;57(5):435-436.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. European cardiovascular disease statistics 2008. 3rd ed. Brussels: European Heart Network; 2008.
    2. Müller-Nordhorn J, Binting S, Roll S et al. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 2008; 29: 1316-1326. Go to original source... Go to PubMed...
    3. Ford ES, Ajani UA, Croft JB et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356: 2388-2398. Go to original source... Go to PubMed...
    4. Palmieri L, Bennett K, Giampaoli S et al. Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health 2010; 100: 684-692. Go to original source... Go to PubMed...
    5. Bennett K, Kabir Z, Unal B et al. Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Community Health 2006; 60: 322-327. Go to original source... Go to PubMed...
    6. Capewell S, Beaglehole R, Seddon M et al. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 2000; 102: 1511-1516. Go to original source... Go to PubMed...
    7. Björck L, Rosengren A, Bennett K et al. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009; 30: 1046-1056. Go to original source... Go to PubMed...
    8. Capewell S, O'Flaherty M. What explains declining coronary mortality? Lessons and warnings. Heart 2008; 94: 1105-1108. Go to original source... Go to PubMed...
    9. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004; 109: 1101-1107. Go to original source... Go to PubMed...
    10. Laatikainen T, Critchley J, Vartiainen E et al. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005; 162: 764-773. Go to original source... Go to PubMed...
    11. Cífková R, Skodová Z, Bruthans J et al. Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008. J Hypertens 2010; 28: 2196-2203. Go to original source... Go to PubMed...
    12. Bruthans J, Cífková R, Lánská V et al. Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007 (odesláno do tisku).
    13. Kotík L. Snížení morbidity a mortality nemocných s chronickými formami ischemické choroby srdeční je především výsledkem konzervativní léčby. Vnitř Lék 2011; 57: 497-501. Go to PubMed...
    14. Boden WE, O'Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516. Go to original source... Go to PubMed...
    15. BARI 2D Study Group. Frye RL, August P, Brooks MM et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. New Engl J Med 2009; 360: 2503-2515. Go to original source... Go to PubMed...
    16. Mehta SR, Granger CB, Boden WE et al. TIMACS Investigators. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009; 360: 2165-2175. Go to original source... Go to PubMed...
    17. de Winter RJ, Windhausen F, Cornel JH et al. Invasive Versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005; 353: 1095-1104. Go to original source... Go to PubMed...
    18. Van de Werf F, Bax J, Betriu A et al. ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-2945. Go to original source... Go to PubMed...
    19. Capewell S, O'Flaherty M. Rapid mortality falls after risk-factor changes in populations. Lancet 2011; published online March 16. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)62302-1/fulltext#. DOI: 10.1016/S1016/S0140-6736(10)62302-1. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.